EGF and non-small cell lung carcinoma: In a study using A549, H460, and H1792 NSCLC cell lines, the in vitro assessment of the anti-proliferative effects of THC and CBD separately and in combination showed that THC (30 μM) and CBD (30 μM) significantly suppressed NSCLC cell proliferation through the inhibition of epithelial-to-mesenchymal transition (EMT) and epidermal growth factor (EGF)-induced cell migration [31].